Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hacene

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Cancer & Clinical Oncology|August 1, 1984
Immunohistochemical detection of alphalactalbumin in breast lesionsV Le Doussal, P F Zangerle, J Collette, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000V Le Doussal, P F Zangerle, J Collette, et al.
La Nouvelle Presse Medicale|August 5, 1981
[Prognostic histopathological features of malignant melanoma. New statistical approaches (author's transl)]V Le Doussal, M Brunet, P Guérin, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Breast cyst fluid proteins and breast cancerP F Zangerle, F Spyratos, V Le Doussal, et al.
Journal of the National Cancer Institute|January 19, 1994
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosisS M Scholl, C Pallud, F Beuvon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric studyJ M Riedinger, J Wafflart, G Ricolleau, et al.
Lancet (London, England)|November 11, 1989
Cathepsin D: an independent prognostic factor for metastasis of breast cancerF Spyratos, T Maudelonde, J P Brouillet, et al.
Cancer Letters|November 2, 2001
ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinomaI Bièche, P Onody, F Lerebours, et al.
British Journal of Cancer|January 1, 1997
Comparison of a new microplate oestrogen receptor (ER) enzyme immunoassay with other ER detection methodsV Delage, S Deytieux, V Le Doussal, et al.
Bulletin Du Cancer|January 1, 1991
[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]P M Martin, S Romain, F Spyratos, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Cancer & Clinical Oncology|August 1, 1984
Immunohistochemical detection of alphalactalbumin in breast lesionsV Le Doussal, P F Zangerle, J Collette, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000V Le Doussal, P F Zangerle, J Collette, et al.
La Nouvelle Presse Medicale|August 5, 1981
[Prognostic histopathological features of malignant melanoma. New statistical approaches (author's transl)]V Le Doussal, M Brunet, P Guérin, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Breast cyst fluid proteins and breast cancerP F Zangerle, F Spyratos, V Le Doussal, et al.
Journal of the National Cancer Institute|January 19, 1994
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosisS M Scholl, C Pallud, F Beuvon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric studyJ M Riedinger, J Wafflart, G Ricolleau, et al.
Lancet (London, England)|November 11, 1989
Cathepsin D: an independent prognostic factor for metastasis of breast cancerF Spyratos, T Maudelonde, J P Brouillet, et al.
Cancer Letters|November 2, 2001
ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinomaI Bièche, P Onody, F Lerebours, et al.
British Journal of Cancer|January 1, 1997
Comparison of a new microplate oestrogen receptor (ER) enzyme immunoassay with other ER detection methodsV Delage, S Deytieux, V Le Doussal, et al.
Bulletin Du Cancer|January 1, 1991
[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]P M Martin, S Romain, F Spyratos, et al.
Pageof 5